MINING The Boulle Mining Group (''BMG'') is a division of the Jean Boulle Group which over the years has discovered some of the largest mineral resources projects in the world. KNOW MORE MEDTECH Jean Boulle Medtech Ltd. is active in a wide range of pioneering and lifesaving medical technologies KNOW MORE THERAPEUTICS Boulle Therapeutics identifies, invests in, and supports innovations that have the potential to save lives and improve the quality of life for large numbers of people KNOW MORE AGRICULTURE The Jean Boulle Group's Indian Ocean Fields Ltd. is one of the largest shareholders of Omnicane Limited, a leading producer of sugarcane and power generation in Mauritius KNOW MORE LUXURY PRODUCTS The Jean Boulle Group has more than 50 years’ experience in all facets of the diamond industry: mining, sourcing, purchasing, cutting and polishing high-quality natural diamonds. KNOW MORE


The Jean Boulle Group acquires promising assets and projects and optimizes their structure, management and development with private and public investment.


Trained Therapeutix Discovery Inc. Appoints Dr. Willem Mulder as Chief Scientific Officer - Expert in Use of Nanomaterials as Immunotherapeutics, Former Professor at Icahn School of Medicine at Mount Sinai, and Professor at Eindhoven University of Technology and Radboud University Medical Center

5 January, 2021
Trained Therapeutix Discovery, Inc. (“TTxD”), an immunotherapy biotech company founded by Jean Boulle Therapeutics, announces the appointment of Prof. Dr. Willem Mulder as Chief Scientific Officer effective 1 January 2021. [...]

Jean Boulle Group Partners with SISA to advance Greenland Anorthosite Mining project

24 December, 2020
The Jean Boulle Group is pleased to note the announcement today by Greenland Anorthosite Mining ApS (“GAM” or “the Company”) that the Greenlandic pension fund SISA Pension has invested in the Company. GAM is a mineral exploration and development company which has the potential to become a major supplier to the global fiberglass marketplace. [...]

Jean Boulle Medtech's company, VDYNE, Inc., receives major industry innovation award in recognition of ground-breaking transfemoral tricuspid valve replacement technology

December 14, 2020 - VDYNE, INC, Inc. ("VDYNE" or "the Company"), a privately held medical device company founded by Jean Boulle Medtech to develop a transcatheter replacement valve for the treatment of tricuspid regurgitation ("TR"), announced today that it is the co-recipient of the Innovations in Cardiovascular Interventions & High-Tech Science Industry World Startup Competition 2020. This award is one of the world's most significant and prestigious awards for medical interventions (ICI 2020). [...]

25B Boulevard Royal
L2449 Luxembourg
Grand Duchy Luxembourg

Tel: +352 222 512
Fax: +352 222 413

Copyright © 2019 Jean Boulle Group. All rights reserved.